Arvindbhai
Arvindbhai
Arvindbhai
Reg. No. : 1052500782 Reg. Date : 03-May-2021 15:01 Ref.No : Collected On : 03-May-2021 15:01
Name : Mr. ARVINDBHAI NARSINHBHAI PATEL Reported Date : 04-May-2021
Age : 60 Years Gender : Male Pass. No. : Dispatch At : o ucc
Ref. By : Tele No. : 9998882354
Location : UNIPATH COLLECTION CENTER @ ANAND
Note :
For results with S-Gene negative and other two genes positive: These samples may have 69-70del S gene mutation which is
usually associated with, but not limited to B.1.1.7 variant (UK VOC-202012/01). Since our assay is designed to detect multiple
genetic targets (ORF and N genes along with S gene), the overall test sensitivity is not impacted by this variant. (Ref:
https://www.fda.gov/medical-devices/letters-health-care-providers/genetic-variants-sars-cov-2-may-lead-false-negative-
results-molecular-tests-detection-sars-cov-2)
1 - Test report should be correlated with the clinical presentation and findings.
2 - The LOD for the three target genes is 10 copies/reaction.
3 - A negative result does not rule out 2019-nCoV and should not be used as the sole basis for treatment or other patient
management decisions.
4 - A number of factors could lead to a negative result in an infected individual including 1) Poor quality of the specimen,
containing nadequate patient material or non-representative specimen 2) The specimen was collected late or very
early in the infection. Optimum specimen types and timing for peak viral levels during infections caused by 2019-
nCoV have not been determined. Collection of multiple samples from the same patient may be necessary to detect
the virus 3) The specimen was not handled and shipped appropriately 4) Technical reasons inherent in the test (like
Virus mutation or PCR inhibition) 5) Inadequate numbers of organisms are present in the specimen
5 - Reports will be provided to the treating physician, who is requested to communicate the same to the patient and follow
MOHFW policy for isolation, quarantine and treatment of all positive cases along with contact tracing as
recommended.
6 - Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease.
7 - The repeat specimens may be considered after a gap of 2-4 days after the collection of the first specimen for additional
testing if required.
8 - Categories of viral load is based on Cycle threshold (Ct) detected by RT PCR.
9 - High viral load: up to 23; Moderate viral load: 24 to 31; Low/Mild viral load: 32 to 35